Update on quetiapine in the treatment of bipolar disorder: Results from the BOLDER studies

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 6, 2007, Pages 847-853

  Gajwani, Prashant ^a   Muzina, David J ^b   Kemp, David E ^a   Gao, Keming ^a   Calabrese, Joseph R ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Bipolar disorder; BOLDER studies; Quetiapine

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; LORAZEPAM; OLANZAPINE; PLACEBO; QUETIAPINE; ZOLPIDEM TARTRATE;

ARTICLE; BEDTIME DOSAGE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EFFECT SIZE; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HAMILTON SCALE; HOSPITALIZATION; HUMAN; HYPOMANIA; MANIA; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MORBIDITY; MORTALITY; PARALLEL DESIGN; SIDE EFFECT; SUICIDE ATTEMPT; UNITED STATES; WEIGHT GAIN;

EID: 38149016777     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Altshuler LL, Gitlin MJ, Mintz J, et al. 2002. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry, 63:807-11.
2. Angst J. 1998. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord, 50:143-51.
3. Calabrese JR, Hirschfeld RMA, Frye MA, et al. 2004. Impact of depressive symptoms as compared with manic symptoms in bipolar disorder: results of a US community-based sample. J Clin Psychiatry, 65:1499-504.
4. Calabrese JR, Keck PE, Macfadden W, et al. 2005. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I and II depression. Am J Psychiatry, 162:1351-60.
5. Cookson J, Keck PE, Ketter TA, et al. 2007. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Int Clin Psychopharmacol, 22:93-100.
6. Gajwani P, Kemp DE, Muzina DJ, et al. 2006. Treatment of acute mania: An update on new medications. Current Psychiatric Reports, Bipolar Disorder, 8:504-9.
7. Goldstein J, Cristoph G, Grimm S, et al. 2007. Unique mechanism of action for antidepressant properties of the Atypical antipsychotic Quetiapine. Poster presented at APANR336:142.
8. Goodwin FK, Jamison KR. 1990. Manic-depressive illness. New York, NY: Oxford University Press.
9. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry, 23:56-62.
10. Himmelhoch JM, Thase ME, allinger AG, et al. 1991. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry, 148:910-16.
11. Hlastala SA, Frank E, Malinger AG, et al. 1997. Bipolar depression: an underestimated treatment challenge. Depress Anxiety, 5:73-83.
12. Judd LL, Akiskal HS, Schetter PJ, et al. 2002. The long term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry, 59:503-37.
13. Judd LL, Akiskal HS, Schettler PJ, et al. 2003. A Prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry, 60:261-9.
14. Kessler RC, Chiu WT, Demler O, et al. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 62:617-27.
15. Leverich GS, Altshuler LL, Frye MA, et al. 2003. Factors associated with suicide attempts in 648 patients with bipolar disorder in the stanley foundations bipolar network. J Clin Psychiatry, 64:506-15.
16. Leverich GS, Altshuler LL, Frye MA, et al. 2006. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertaline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry, 163:232-9.
17. Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry, 134:382-9.
18. Muller MJ, Himmerich H, Kienzle B, et al. 2003. Differentiating moderate and severe depression using Montgomery-Åsberg depression rating scale (MADRS). J Affect Disord, 77:255-60.
19. Peet M. 1994. Induction of mania with selective serotonin re-uptake inhibitors and Tricyclic antidepressants. Br J Psychiatry, 164:549-50.
20. Post RM, Denicoff KD, Leverich GS, et al. 2003. Morbidity I 258 bipolar outpatients followed for 1 year with daily prospective rating on the NIMH life chart method. J Clin Psychiatry, 64:680-90.
21. Sachs GS, Nierenberg AA, Calabrese JR, et al. 2007. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Eng J Med, 356:1711-22.
22. Thase ME, Macfadden W, Weisler R, et al. 2006. Efficacy of quetiapine monotherapy in Bipolar I and II depression. J Clin Psychopharmacol, 26:600-9.
23. Tohen M, Vieta E, Calabrese JR, et al. 2003. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry, 60:1079-88.
24. Young RC, Biggs JT, Ziegler VE, et al. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry, 133:429-35.